In the present study, the decreased concentrations of adiponectin and high levels of leptin in the obesity and diabetes groups seem to downregulate the cardiometabolic effects of the former. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.